Pages that link to "Q34616057"
Jump to navigation
Jump to search
The following pages link to The development of highly potent inhibitors for porcupine (Q34616057):
Displaying 30 items.
- Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in Cancer (Q26747432) (← links)
- Chemical Disruption of Wnt-dependent Cell Fate Decision-making Mechanisms in Cancer and Regenerative Medicine (Q26796673) (← links)
- ABC transporters in CSCs membranes as a novel target for treating tumor relapse (Q33879326) (← links)
- Porcupine is not required for the production of the majority of Wnts from primary human astrocytes and CD8+ T cells (Q35125035) (← links)
- Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics (Q35869295) (← links)
- Wnt addiction of genetically defined cancers reversed by PORCN inhibition (Q36292664) (← links)
- Lrp5 Has a Wnt-Independent Role in Glucose Uptake and Growth for Mammary Epithelial Cells (Q36736195) (← links)
- Biochemical Analysis of Tankyrase Activity in Zebrafish In Vitro and In Vivo (Q38410995) (← links)
- Genetically engineered mouse models to evaluate the role of Wnt secretion in bone development and homeostasis (Q38714183) (← links)
- Blocking Wnt Secretion Reduces Growth of Hepatocellular Carcinoma Cell Lines Mostly Independent of β-Catenin Signaling (Q38730840) (← links)
- WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited (Q38908764) (← links)
- Modulating the wnt signaling pathway with small molecules (Q39102292) (← links)
- Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors (Q42281552) (← links)
- Structure-Based Design of 1,4-Dibenzoylpiperazines as β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction Inhibitors (Q42787521) (← links)
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors. (Q46021160) (← links)
- Fatty acylation of Wnt proteins (Q46888992) (← links)
- Wnt9a Is Required for the Aortic Amplification of Nascent Hematopoietic Stem Cells (Q46906887) (← links)
- Development of a triazole class of highly potent Porcn inhibitors (Q47139083) (← links)
- Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies (Q47239374) (← links)
- WNT Signaling in Cardiac and Vascular Disease. (Q47299786) (← links)
- Disparate levels of beta-catenin activity determine nephron progenitor cell fate. (Q52715978) (← links)
- Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer (Q57798889) (← links)
- Protein Lipidation in Cell Signaling and Diseases: Function, Regulation, and Therapeutic Opportunities (Q88964866) (← links)
- Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex (Q89616226) (← links)
- Development of Teleost Intermuscular Bones Undergoing Intramembranous Ossification Based on Histological-Transcriptomic-Proteomic Data (Q90225196) (← links)
- Installation of a cancer promoting WNT/SIX1 signaling axis by the oncofusion protein MLL-AF9 (Q90352766) (← links)
- Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines (Q91816558) (← links)
- WNT Signaling in Disease (Q92422653) (← links)
- Targeting cancer stem cells in drug discovery: Current state and future perspectives (Q92512238) (← links)
- In vitro reconstitution of Wnt acylation reveals structural determinants of substrate recognition by the acyltransferase human Porcupine (Q93015484) (← links)